Alkaptonuria in Turkey: Clinical and molecular characteristics of 66 patients
- 1 May 2021
- journal article
- research article
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 64 (5) , 104197
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trialThe Lancet Diabetes & Endocrinology, 2020
- Alkaptonuria – Many questions answered, further challenges beckonAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2019
- Homogentisate 1,2-dioxygenase (HGD) gene variants, their analysis and genotype–phenotype correlations in the largest cohort of patients with AKUEuropean Journal of Human Genetics, 2019
- Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria CentreMolecular Genetics and Metabolism, 2018
- Natural history of alkaptonuria revisited: analyses based on scoring systemsJournal of Inherited Metabolic Disease, 2011
- Identification of alkaptonuria in the general population: a United Kingdom experience describing the challenges, possible solutions and persistent barriersJournal of Inherited Metabolic Disease, 2011
- Mutation spectrum of homogentisic acid oxidase (HGD) in alkaptonuriaHuman Mutation, 2009
- Allelic heterogeneity of alkaptonuria in Central EuropeEuropean Journal of Human Genetics, 1999
- Mutation and Polymorphism Analysis of the Human Homogentisate 1,2-Dioxygenase Gene in Alkaptonuria PatientsThe American Journal of Human Genetics, 1998
- Molecular defects in alkaptonuriaCytogenetic and Genome Research, 1997